WIZP News and Press, Wize Pharma Inc From 04/30/19

HOD HASHARON, Israel , April 30, 2019 /PRNewswire/ --  Wize Pharma , Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it will present at the ThinkEquity Conference on May 2, 2019 at 2:30 pm ET at the...

Thinly traded nano cap Wize Pharma ( OTCQB:WIZP -8.5% ) is down on more than a 4x surge in volume, albeit on turnover of only 128K shares, in reaction to its announcement of final results from a Phase 2 clinical trial evaluating lead drug LO2A , an eye drop, in patients with conjunctiv...

HOD HASHARON, Israel , April 29, 2019 /PRNewswire/ -- Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced completion of statistical analysis of the Phase II clinical results from its trial of LO...

InsiderInsights' Daily Round Up articles rate the "significance" of the top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the significance of an insider transaction, however, and there are many more "Signifi...

HOD HASHARON, Israel, April 24, 2019 /PRNewswire/ --  Wize Pharma, Inc.  ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today the Company's Chief Executive Officer, Mr...

HOD HASHARON, Israel, April 23, 2019 /PRNewswire/ --  Wize Pharma, Inc.  ("Wize Pharma" or the "Company") (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, is pleased to announce that Mr. Mark Sieczkarek has bee...

Editor's note: This is a transcript version of our recent podcast on Cannabics Pharmaceuticals ( OTCQB:CNBX ). Listen to or subscribe to The Cannabis Investing Podcast on Libsyn , SoundCloud or Apple Podcasts/iTunes . Introduction Rena Sherbill : Jona...

By Rena Sherbill Jonathan Liss and I covered the CannaTech conference in Tel Aviv that ran from April 1 to 2. We talked with a wide variety of attendees and presenters - from executives and scientists to venture capitalists, money managers, marketers and journalists. We'll be ...

Editor's note: This is a transcript version of our recent podcast on Cannabics Pharmaceuticals (CNBX). Listen to or subscribe to The Cannabis Investing Podcast on Libsyn , SoundCloud or Apple Podcasts/iTunes . Introduction Rena Sherbill: Jonathan Liss and...

By Rena Sherbill Jonathan Liss and I covered the CannaTech conference in Tel Aviv that ran from April 1-2. We talked with a wide variety of attendees and presenters - from executives and scientists to venture capitalists, money managers, marketers and journalists. We'll be rel...